Paper
0
Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts
Authors
Journal
Published
Nov 4, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
or